EBITDA

A South Korean firm has solved a hidden flaw in industrial magnets, promising a leap in efficiency for battery, recycling, and mining industries.

A new partnership combines 3D depth with panoramic visuals, creating an unparalleled movie experience. But is it enough to win the premium cinema war?

A $277M secondary offering sees MIAX shareholders cash in, but the company itself isn't taking any money. Here’s what that says about its financial power.

Rio2 diversifies from Chilean gold to Peruvian copper, securing immediate cash flow and a key position in the energy transition. What does this mean for investors?

Lument Finance Trust's latest dividend boasts an attractive yield, but recent adjustments raise questions about the health of commercial real estate.

With a $2.5B boost from Blue Owl, Finance of America aims to move beyond reverse mortgages and reshape how millions of retirees access their home equity.

AMC's key governance reforms failed despite 90% voter support, stymied by low turnout. Meanwhile, a major share increase passed. What does this mean?

Serina Therapeutics poaches a top chemist to expand its POZ platform, signaling a major push beyond Parkinson's into new, high-value drug markets.

As John Lindsay retires, H&P anoints tech-savvy insider Trey Adams. A look at how this smooth transition secures a legacy of innovation.

Compass predicts a balanced 2026 housing market, but a deeper look reveals a split: modest relief for many and a luxury boom fueled by AI-driven wealth.

A new partnership between KBRA Analytics and Intex Solutions streamlines CMBS analysis, promising to enhance risk management in volatile economic times.

Excelerate Energy signals deep confidence with a new $75M share buyback, balancing shareholder rewards with an ambitious global expansion in the LNG market.

AutoNation's latest acquisition in Baltimore is more than just a line item. It's a strategic move in the high-stakes game of auto retail consolidation.

A routine filing reveals a major strategic play. See how BridgeBio Oncology uses special equity grants to attract top minds in the fierce race for a cancer cure.

Argan's repeated dividend hikes and record backlog reflect deep confidence, positioning it to capitalize on surging demand for critical energy infrastructure.

As TD SYNNEX prepares its full-year report, the results will be a crucial test of its AI strategy and a key indicator for the entire IT ecosystem.

KBRA rates a $328M mortgage trust with significant 'non-prime' loans, signaling a boom in a market segment that balances risk with investor demand.

Beyond a new logo, WaterFurnace's rebranding reveals a major strategic shift to dominate commercial markets, fueled by policy tailwinds and surging demand.

A top advisor's move to independence reveals a major shift in how ultra-high-net-worth families are securing multi-generational wealth and resilience.

A rejected $307M Danone offer and claims of poor governance fuel a bitter proxy fight at Lifeway Foods, pitting CEO against her largest shareholder—her brother.